FDA official logo
GSRS logoPFDA official logo

TIDUTAMAB

UNII:88635FW2QX
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:TIDUTAMAB
GSRS Full Record:
88635FW2QX
i

  • 2148354-90-7
  • ANTI-SSTR2/CD3 MONOCLONAL ANTIBODY XMAB18087
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB18087 .GAMMA.1-CHAIN), (265->231'),(268->234')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1, ANTI-(HUMAN SOMATOSTATIN RECEPTOR 2) (HUMAN-MUS MUSCULUS MONOCLONAL XMAB18087 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL XMAB18087 .KAPPA.-CHAIN
  • IMMUNOGLOBULIN HALF-G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS SSTR2 (SOMATOSTATIN RECEPTOR 2) AND HOMO SAPIENS CD3 EPSILON (CD3E, LEU-4)), MONOCLONAL ANTIBODY, BISPECIFICGAMMA1 HEAVY CHAIN ANTI-SSTR2 (1-451) (VH (HOMO SAPIENS IGHV3-48*03 (90.8%)-(IGHD)-IGHJ4*01 (100%)) (8.8.15) (1-122)-HOMO SAPIENS IGHG1*03V (CH1 N114>D (213), R120>K (219) (123-220), HINGE 1-15 (221-235), CH2 E1.4>P (238), L1.2>V (239), G1.1>A (240), S29>K (271), Q84.2>E (299) (236-344), CH3 E12 (360), M14 (362), L24>D (372), K26>S (374), N44>D (388), Q97>E (422), N100>D (425) (345-449), CHS (450-451)) (123-451)), (225-219')-DISULFIDE WITH KAPPA LIGHT CHAIN ANTI-SSTR2 (1'-219') (V-KAPPA (HOMO SAPIENS IGKV4-1*01 (91.8%)-IGKJ4*01 (100.0%)) (12.3.8) (1'-112')-HOMO SAPIENS IGKC*01 (100%) A45.1 (158), V101 (196) (113'-219'))HEAVY CHAIN SCFV-H-CH2-CH3, ANTI-CD3E (1-485) (VH (HOMO SAPIENS IGHV3-73*01 (87.0%)-(IGHD)-IGHJ6*01 (90.9%)) (8.10.16) (1-125)-20-MER LINKER (126-145)-VLAMBDA (MUS MUSCULUS IGLV1*01 (80.6%)-IGLJ1*01 (100%)/HOMO SAPIENS IGLV7-46*01 (76.8%)-IGHJ3*02 (100%)) (9.3.9) (146-254)-IGHG1*03 (HINGE 1-15 C5>S (259) (255-269)-CH2 E1.4>P (272), L1.2>V (273), G1.1>A (274), S29>K (305) (270-378),CH3 E12 (394), E13>Q (395), M14 (396), S20>K (402)(379-483), CHS (484-485)) (1-485))(231-265'':234-268'')-BISDISULFIDE
  • TIDUTAMAB [USAN]
  • Tidutamab [WHO-DD]
  • XMAB-18087
  • XMAB18087
  • tidutamab [INN]




UNII - 88635FW2QX | UNII Search Service